Group 1 - The Shanghai Stock Exchange Sci-Tech Innovation Board 100 Index rose by 0.46% as of July 17, 2025, with notable increases in constituent stocks such as Shengyi Electronics (up 13.37%) and Baiotai (up 6.51%) [1] - The Huaxia Sci-Tech 100 ETF (588800) also saw a rise of 0.50%, marking its fifth consecutive increase, with a latest price of 1 yuan and a trading volume of 27.1854 million yuan [1] - The latest scale of the Huaxia Sci-Tech 100 ETF reached 2.934 billion yuan [1] Group 2 - The adjustment of the national basic medical insurance and commercial health insurance innovative drug catalog officially started, with eligible applicants able to submit online applications from July 11 to 20 [1] - The domestic policy continues to favor innovative drugs, establishing a dynamic adjustment mechanism for new drug access to the medical insurance catalog [2] - The expenditure of employee medical insurance funds increased from 1.29 trillion yuan in 2020 to 1.91 trillion yuan in 2024, reflecting a growth of over 600 billion yuan in five years, indicating a rising demand for pharmaceuticals [2]
冲击五连涨!科创 100 ETF华夏(588800)早盘势头强劲